Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emend for CRINV in pancreatic cancer patients
NCT01534637Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in nausea ((none)), Vomiting, sponsored by Wake Forest University Health Sciences. Started Aug 2006; status: completed.
02
Drugs
aprepitant
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT01534637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534637.